Conclusion: Health care providers must consider the efficacy, GI and cardiovascular risks, concomitant medications, and costs when determining the appropriateness of COX-2-selective NSAID therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback